PCI Biotech Holding ASA (OSL:PCIB)
0.2100
-0.0240 (-10.26%)
Mar 13, 2026, 4:00 PM CET
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 7.84 million as of March 13, 2026. Its market cap has decreased by -86.87% in one year.
Market Cap
7.84M
Enterprise Value
-5.50M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 7.84M, a decrease of -91.96%. That is a compound annual growth rate of -13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 7.84M | -14.63% |
| Dec 30, 2025 | 9.18M | -79.29% |
| Dec 30, 2024 | 44.34M | -43.29% |
| Dec 29, 2023 | 78.20M | 2.20% |
| Dec 30, 2022 | 76.52M | -85.26% |
| Dec 30, 2021 | 519.21M | -50.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.69B |
| Circio Holding ASA | 1.14B |
| ArcticZymes Technologies ASA | 1.10B |
| Nykode Therapeutics AS | 969.84M |
| Lytix Biopharma AS | 811.30M |
| Zelluna ASA | 467.60M |
| SoftOx Solutions AS | 183.63M |
| EXACT Therapeutics AS | 139.18M |